Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Cardiology|May 28, 2016
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinionMarkku S Nieminen, Michael Buerke, Alain Cohen-Solál, et al.International Journal of Cardiology|August 8, 2016
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paperDimitrios Farmakis, Julian Alvarez, Tuvia Ben Gal, et al.International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.European Journal of Heart Failure|June 13, 2023
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyOvidiu Chioncel, Marianna Adamo, Maria Nikolaou, et al.Pageof 7